A medical study out of New Jersey shows the drug hydroxychloroquine may help people with mild symptoms of COVID-19.
“We make it clear we can’t recommend it to be given,” said Andrew Ip, a lymphoma physician and director of the Division of Outcomes and Value Research at the John Theurer Cancer Center. “This is only an observational study. We can only recommend it in the context of a clinical trial. There may be a benefit for using this drug in an outpatient setting.”
The study was conducted by Hackensack Meridian Health on outpatients in 2020 and found those who took hydroxychloroquine were less likely to end up in the hospital.
Ip said that more than 100 patients received the drug between March and May, and just over 1 in 5 patients landed in the hospital after the fact. Meanwhile, almost 1 in 3 of the more than 1,000 patients who did not receive the drug required hospitalization.
Read more at Washington Examiner.